Personal Genome Diagnostics' CancerSelect Targeted Gene Panel

Personal Genome Diagnostics has launched its CancerSelect targeted gene panel through its MyPersonalGenome service. The CancerSelect panel detects alterations in 88 well-characterized genes that include all targets of currently available or investigational cancer treatment options, the firm said. PGDx analyzes the CancerSelect genes using next-generation sequencing at extremely high coverage and proprietary PGDx technologies to identify a comprehensive list of genetic alterations, including point mutations, copy number alterations, and genetic rearrangements.